Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Are We There Yet?

David Borenstein, MD  |  Issue: April 2011  |  April 13, 2011

By understanding that this campaign is a place for us to start, not the final destination, we can create a culture of communication with different target audiences that will support us for years to come. Although this specific campaign will eventually draw to an end—or at the very least change direction—I see it as the initial step towards a long and successful PR program for the ACR. There are other audiences that need to hear our messages. There are other topics to discuss, goals and objectives to reach, and ways to raise the visibility of rheumatology. We’ve only just begun our public relations efforts, and there are many directions we can go at the end of this campaign. Our willingness to engage as members not only in this campaign, but in the future campaigns and PR work of the ACR will be vital to our long-term success.

So, Are We There Yet?

Not yet, but we are getting closer, and adding an official PR program to the ACR’s already established efforts—including a media relations program that positions ACR members as the go-to rheumatology experts for media, advocacy efforts, practice-management books and articles that advise readers on how to market their practices, and collaborative work with other organizations—will advance us greatly.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

We have focused our efforts to determine where we need to start with this campaign, and we are preparing for a sustained effort. If we remain willing to keep going, looking for new ways to increase the visibility of rheumatology, we are likely to create positive changes that go beyond name recognition but ripple into other areas of the ACR’s work, such as building the workforce and fundraising.

I’m confident the ACR has moved into an era of using public relations to increase the visibility of our specialty. I share in my fellow members’ excitement to see how far we can advance rheumatology through this campaign, and I look forward to seeing where we can go in the years to follow.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Last month, the Communications and Marketing Committee started placing campaign materials on the ACR website. This section of the website will keep members informed of, and offer opportunities to engage in, the campaign. I encourage you to visit this section of the website often as it becomes more robust with campaign materials and updates and to learn how you can help advance rheumatology among influencers—getting us one step closer to “there.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & AdvocacyPresident's Perspective Tagged with:AC&RCongressLegislationRheumPAC

Related Articles

    Five Ways to Get Involved in the American College of Rheumatology (ACR) Simple Tasks Campaign

    April 6, 2012

    Last September, the ACR launched its first public relations campaign, called Simple Tasks. Here are five ways you can become a part of this important campaign.

    American College of Rheumatology Simple Tasks Campaign Marks One Year

    September 5, 2012

    Campaign raises awareness about rheumatologists and rheumatic diseases.

    ACR Wins Top Honors for Public Education Campaign

    February 10, 2022

    Every year, the Ragan PR Daily Awards recognize the most outstanding public relations campaigns and initiatives. Due to the ACR’s work to elevate the voices of patients living with rheumatic diseases, its 2020 Rheumatic Diseases Awareness Month campaign has received three of these major awards.

    ACR launches its First Public Relations campaign

    November 1, 2010

    Many of us have experienced that look—confusion—when you tell someone that you work in rheumatology. It happens at dinner parties, in line at the grocery store, and during conversations on airplanes. The look can open the door to conversations about rheumatology. However, when the influential people whose decisions affect our specialty don’t know who we…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences